2018. Antiarrhythmic efficacy and safety of 1C class anti­­arrhythmic agents ethacizin and propafenone in patients with arterial hypertension and frequent recurrences of atrial fibrillation. Ukrainian Journal of Cardiology. 25, 2 (May 2018), 43–49.